Buscador de publicaciones<< Volver
Tamargo J, Le Heuzey JY, Mabo P
Narrow therapeutic index drugs: a clinical pharmacological consideration to flecainide.
Eur. J. Clin. Pharmacol.. 2015 May;71(5):549-67, PMID: 25870032
The therapeutic index (TI) is the range of doses at which a medication is effective without unacceptable adverse events. Drugs with a narrow TI (NTIDs) have a narrow window between their effective doses and those at which they produce adverse toxic effects. Generic drugs may be substituted for brand-name drugs provided that they meet the recommended bioequivalence (BE) limits. However, an appropriate range of BE for NTIDs is essential to define due to the potential for ineffectiveness or adverse events. Flecainide is an antiarrhythmic agent that has the potential to be considered an NTID. This review aims to evaluate the literature surrounding guidelines on generic substitution for NTIDs and to evaluate the evidence for flecainide to be considered an NTID.
PHARMACOLOGY & PHARMACY
Una iniciativa de
